LIke ThisLIke ThisLIke This

Andrea  Patenaude, PhD

Andrea Patenaude
Research Center:
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Medicine Research
Hematology/Oncology Research
Hospital Title:
Associate in Medicine
Academic Title:
Associate Professor of Psychology, Harvard Medical School
Research Focus Area:
Psychosocial aspects of survivorship
Contact Via Email
Send an email to SendYour Name*Your Email Address*Subject*Comments*

Research Overview

Andrea Patenaude's research, which encompasses studies of both pediatric and adult cancer patients, involves psychosocial aspects of cancer genetics and survivorship.

Patenaude and colleagues recently completed a project assessing the psychological impact of prophylactic mastectomy (PM), a risk-reduction procedure recommended to women at high risk for breast or ovarian cancer. Interviews with 71 women who have undergone PM and 37 women considering the surgery revealed that all women considering surgery and about two-thirds of those who had undergone PM would advise pre-surgical psychological consultation. In addition, women who had undergone PM also would advise post-surgical psychological consultation to deal with issues of body image, self-esteem, and marital interaction.

Other recent projects include:

  • A study comparing more and less intensive programs of genetic counseling for hereditary breast-ovarian cancer susceptibility.
  • An evaluation of parent-child communication about breast/ovarian cancer genetic testing.
  • A project assessing maternal reaction, family functioning, and expectations for change at the completion of a child's successful treatment for leukemia.
  • A study of health behaviors and risk-taking in teen-age survivors of pediatric cancer.
  • A study with Dr. Tony Meyer and Dr. Kathy Vannatta on the social functioning of pediatric brain tumor survivors.

About Andrea Patenaude

Dr. Patenaude received her PhD from Michigan State University. She is the recipient of a Fiftieth Anniversary Award, Scholars in Medicine Fellowship, Harvard Medical School, 2001; the Rosalie G. Weiss Award, American Psychological Foundation, 2000; and a Presidential Citation, American Psychological Association, 1999.


Publications powered by Harvard Catalyst Profiles
  1. Young AL, Butow PN, Vetsch J, Quinn VF, Patenaude AF, Tucker KM, Wakefield CE. Family Communication, Risk Perception and Cancer Knowledge of Young Adults from BRCA1/2 Families: a Systematic Review. J Genet Couns. 2017 Jun 30.
  2. Lim Q, McGill BC, Quinn VF, Tucker KM, Mizrahi D, Patenaude AF, Warby M, Cohn RJ, Wakefield CE. Parents' attitudes toward genetic testing of children for health conditions: A systematic review. Clin Genet. 2017 Feb 07.
  3. Patenaude AF, Schneider KA. Issues Arising in Psychological Consultations to Help Parents Talk to Minor and Young Adult Children about their Cancer Genetic Test Result: a Guide to Providers. J Genet Couns. 2017 Apr; 26(2):251-260.
  4. Liptak C, Brinkman T, Bronson A, Delaney B, Chordas C, Brand S, Patenaude AF, Muriel AC, Manley P. A social program for adolescent and young adult survivors of pediatric brain tumors: The power of a shared medical experience. J Psychosoc Oncol. 2016 Nov-Dec; 34(6):493-511.
  5. Travado L, Breitbart W, Grassi L, Fujisawa D, Patenaude A, Baider L, Connor S, Fingeret M. 2015 President's Plenary International Psycho-oncology Society: psychosocial care as a human rights issue-challenges and opportunities. Psychooncology. 2017 Apr; 26(4):563-569.
  6. Devine KA, Bukowski WM, Sahler OJ, Ohman-Strickland P, Smith TH, Lown EA, Patenaude AF, Korones DN, Noll RB. Social Competence in Childhood Brain Tumor Survivors: Feasibility and Preliminary Outcomes of a Peer-Mediated Intervention. J Dev Behav Pediatr. 2016 Jul-Aug; 37(6):475-82.
  7. Georgiou G, Wakefield CE, McGill BC, Fardell JE, Signorelli C, Hanlon L, Tucker K, Patenaude AF, Cohn RJ. Genetic testing for the risk of developing late effects among survivors of childhood cancer: Consumer understanding, acceptance, and willingness to pay. Cancer. 2016 Sep 15; 122(18):2876-85.
  8. Patenaude AF, Pelletier W, Bingen K. Response: A Call for Psychosocial and Palliative Care Training Standards for Pediatric Hematology-Oncology Physicians, A Reply To: Communication, Documentation, and Training Standards in Pediatric Psychosocial Oncology. Pediatr Blood Cancer. 2016 07; 63(7):1315.
  9. Wakefield CE, Hanlon LV, Tucker KM, Patenaude AF, Signorelli C, McLoone JK, Cohn RJ. The psychological impact of genetic information on children: a systematic review. Genet Med. 2016 Aug; 18(8):755-62.
  10. Turnell A, Rasmussen V, Butow P, Juraskova I, Kirsten L, Wiener L, Patenaude A, Hoekstra-Weebers J, Grassi L. An exploration of the prevalence and predictors of work-related well-being among psychosocial oncology professionals: An application of the job demands-resources model. Palliat Support Care. 2016 Feb; 14(1):33-41.
  11. Show all
  12. Wiener L, Kazak AE, Noll RB, Patenaude AF, Kupst MJ. Interdisciplinary Collaboration in Standards of Psychosocial Care. Pediatr Blood Cancer. 2015 Dec; 62 Suppl 5:S425.
  13. Patenaude AF, Pelletier W, Bingen K. Communication, Documentation, and Training Standards in Pediatric Psychosocial Oncology. Pediatr Blood Cancer. 2015 Dec; 62 Suppl 5:S870-95.
  14. Walsh KS, Noll RB, Annett RD, Patel SK, Patenaude AF, Embry L. Standard of Care for Neuropsychological Monitoring in Pediatric Neuro-Oncology: Lessons From the Children's Oncology Group (COG). Pediatr Blood Cancer. 2016 Feb; 63(2):191-5.
  15. Wiener L, Kazak AE, Noll RB, Patenaude AF, Kupst MJ. Standards for the Psychosocial Care of Children With Cancer and Their Families: An Introduction to the Special Issue. Pediatr Blood Cancer. 2015 Dec; 62 Suppl 5:S419-24.
  16. Mostert S, Lam CG, Njuguna F, Patenaude AF, Kulkarni K, Salaverria C. Hospital detention practices: statement of a global taskforce. Lancet. 2015 Aug 15; 386(9994):649.
  17. Rasmussen V, Turnell A, Butow P, Juraskova I, Kirsten L, Wiener L, Patenaude A, Hoekstra-Weebers J, Grassi L. Burnout among psychosocial oncologists: an application and extension of the effort-reward imbalance model. Psychooncology. 2016 Feb; 25(2):194-202.
  18. Bober SL, Recklitis CJ, Bakan J, Garber JE, Patenaude AF. Addressing sexual dysfunction after risk-reducing salpingo-oophorectomy: effects of a brief, psychosexual intervention. J Sex Med. 2015 Jan; 12(1):189-97.
  19. Salley CG, Hewitt LL, Patenaude AF, Vasey MW, Yeates KO, Gerhardt CA, Vannatta K. Temperament and social behavior in pediatric brain tumor survivors and comparison peers. J Pediatr Psychol. 2015 Apr; 40(3):297-308.
  20. Alderfer MA, Zelley K, Lindell RB, Novokmet A, Mai PL, Garber JE, Nathan D, Scollon S, Chun NM, Patenaude AF, Ford JM, Plon SE, Schiffman JD, Diller LR, Savage SA, Malkin D, Ford CA, Nichols KE. Parent decision-making around the genetic testing of children for germline TP53 mutations. Cancer. 2015 Jan 15; 121(2):286-93.
  21. Salley CG, Gerhardt CA, Fairclough DL, Patenaude AF, Kupst MJ, Barrera M, Vannatta K. Social self-perception among pediatric brain tumor survivors compared with peers. J Dev Behav Pediatr. 2014 Sep; 35(7):427-34.
  22. O'Neill SC, Mays D, Patenaude AF, Garber JE, DeMarco TA, Peshkin BN, Schneider KA, Tercyak KP. Women's concerns about the emotional impact of awareness of heritable breast cancer risk and its implications for their children. J Community Genet. 2015 Jan; 6(1):55-62.
  23. Wiener L, Viola A, Koretski J, Perper ED, Patenaude AF. Pediatric psycho-oncology care: standards, guidelines, and consensus reports. Psychooncology. 2015 Feb; 24(2):204-11.
  24. Mertens AC, Brand S, Ness KK, Li Z, Mitby PA, Riley A, Patenaude AF, Zeltzer L. Health and well-being in adolescent survivors of early childhood cancer: a report from the Childhood Cancer Survivor Study. Psychooncology. 2014 Mar; 23(3):266-75.
  25. Tercyak KP, Mays D, DeMarco TA, Peshkin BN, Valdimarsdottir HB, Schneider KA, Garber JE, Patenaude AF. Decisional outcomes of maternal disclosure of BRCA1/2 genetic test results to children. Cancer Epidemiol Biomarkers Prev. 2013 Jul; 22(7):1260-6.
  26. Mays D, DeMarco TA, Luta G, Peshkin BN, Patenaude AF, Schneider KA, Garber JE, Tercyak KP. Distress and the parenting dynamic among BRCA1/2 tested mothers and their partners. Health Psychol. 2014 Aug; 33(8):765-73.
  27. Bleiker EM, Esplen MJ, Meiser B, Petersen HV, Patenaude AF. 100 years Lynch syndrome: what have we learned about psychosocial issues? Fam Cancer. 2013 Jun; 12(2):325-39.
  28. Patenaude AF, Tung N, Ryan PD, Ellisen LW, Hewitt L, Schneider KA, Tercyak KP, Aldridge J, Garber JE. Young adult daughters of BRCA1/2 positive mothers: what do they know about hereditary cancer and how much do they worry? Psychooncology. 2013 Sep; 22(9):2024-31.
  29. Noll RB, Patel SK, Embry L, Hardy KK, Pelletier W, Annett RD, Patenaude A, Lown EA, Sands SA, Barakat LP. Children's Oncology Group's 2013 blueprint for research: behavioral science. Pediatr Blood Cancer. 2013 Jun; 60(6):1048-54.
  30. Farkas Patenaude A, DeMarco TA, Peshkin BN, Valdimarsdottir H, Garber JE, Schneider KA, Hewitt L, Hamilton J, Tercyak KP. Talking to children about maternal BRCA1/2 genetic test results: a qualitative study of parental perceptions and advice. J Genet Couns. 2013 Jun; 22(3):303-14.
  31. Ach E, Gerhardt CA, Barrera M, Kupst MJ, Meyer EA, Patenaude AF, Vannatta K. Family factors associated with academic achievement deficits in pediatric brain tumor survivors. Psychooncology. 2013 Aug; 22(8):1731-7.
  32. Mai PL, Malkin D, Garber JE, Schiffman JD, Weitzel JN, Strong LC, Wyss O, Locke L, Means V, Achatz MI, Hainaut P, Frebourg T, Evans DG, Bleiker E, Patenaude A, Schneider K, Wilfond B, Peters JA, Hwang PM, Ford J, Tabori U, Ognjanovic S, Dennis PA, Wentzensen IM, Greene MH, Fraumeni JF, Savage SA. Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium. Cancer Genet. 2012 Oct; 205(10):479-87.
  33. Wiener L, Oppenheim D, Breyer J, Battles H, Zadeh S, Patenaude AF. A worldview of the professional experiences and training needs of pediatric psycho-oncologists. Psychooncology. 2012 Sep; 21(9):944-53.
  34. Sharff ME, DeMarco TA, Mays D, Peshkin BN, Valdimarsdottir HB, Garber JE, Schneider KA, Patenaude AF, Tercyak KP. Parenting through genetic uncertainty: themes in the disclosure of breast cancer risk information to children. Genet Test Mol Biomarkers. 2012 May; 16(5):376-82.
  35. Patenaude AF. Commentary: Save the children: direct-to-consumer testing of children is premature, even for research. J Pediatr Psychol. 2011 Nov-Dec; 36(10):1122-7; discussion 1128-9.
  36. Lapointe J, Bouchard K, Patenaude AF, Maunsell E, Simard J, Dorval M. Incidence and predictors of positive and negative effects of BRCA1/2 genetic testing on familial relationships: a 3-year follow-up study. Genet Med. 2012 Jan; 14(1):60-8.
  37. Patenaude AF, Grootenhuis M, Noll R. Pediatric psycho-oncology comes of age: SIOP 2010. Pediatr Blood Cancer. 2011 Jul 01; 56(7):1154.
  38. Patenaude AF. Helping your patients to deal with a predisposition to genetic disease. JAAPA. 2009 Nov; 22(11):68-9.
  39. Demarco TA, Nusbaum RH, Peshkin BN, Patenaude AF, Schneider KA, Garber JE, Valdimarsdottir HB, Tercyak KP. Prevalence and correlates of mothers and fathers attending pretest cancer genetic counseling together. Patient Educ Couns. 2010 Jan; 78(1):29-33.
  40. Patenaude A, Rodriguez-Leyva D, Edel AL, Dibrov E, Dupasquier CM, Austria JA, Richard MN, Chahine MN, Malcolmson LJ, Pierce GN. Bioavailability of alpha-linolenic acid from flaxseed diets as a function of the age of the subject. Eur J Clin Nutr. 2009 Sep; 63(9):1123-9.
  41. Tercyak K, Peshkin B, DeMarco T, Schneider K, Valdimarsdottir H, Garber J, Patenaude A. Parental decisions and outcomes regarding disclosing maternal BRCA1 and 2 test results to children. J Clin Oncol. 2009 May 20; 27(15_suppl):9582.
  42. Patenaude AF, Julian-Reynier C. Cancer genetic testing: current and emerging issues. Psychooncology. 2008 Aug; 17(8):733-6.
  43. Patenaude AF, Orozco S, Li X, Kaelin CM, Gadd M, Matory Y, Mayzel K, Roche CA, Smith BL, Farkas W, Garber JE. Support needs and acceptability of psychological and peer consultation: attitudes of 108 women who had undergone or were considering prophylactic mastectomy. Psychooncology. 2008 Aug; 17(8):831-43.
  44. Peshkin BN, DeMarco TA, Garber JE, Valdimarsdottir HB, Patenaude AF, Schneider KA, Schwartz MD, Tercyak KP. Brief assessment of parents' attitudes toward testing minor children for hereditary breast/ovarian cancer genes: development and validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS). J Pediatr Psychol. 2009 Jul; 34(6):627-38.
  45. Waisbren SE, Bowles H, Hasan T, Zou KH, Emans SJ, Goldberg C, Gould S, Levine D, Lieberman E, Loeken M, Longtine J, Nadelson C, Patenaude AF, Quinn D, Randolph AG, Solet JM, Ullrich N, Walensky R, Weitzman P, Christou H. Gender differences in research grant applications and funding outcomes for medical school faculty. J Womens Health (Larchmt). 2008 Mar; 17(2):207-14.
  46. DeMarco TA, Peshkin BN, Valdimarsdottir HB, Patenaude AF, Schneider KA, Tercyak KP. Role of parenting relationship quality in communicating about maternal BRCA1/2 genetic test results with children. J Genet Couns. 2008 Jun; 17(3):283-7.
  47. Brown RT, Wiener L, Kupst MJ, Brennan T, Behrman R, Compas BE, David Elkin T, Fairclough DL, Friebert S, Katz E, Kazak AE, Madan-Swain A, Mansfield N, Mullins LL, Noll R, Patenaude AF, Phipps S, Sahler OJ, Sourkes B, Zeltzer L. Single parents of children with chronic illness: an understudied phenomenon. J Pediatr Psychol. 2008 May; 33(4):408-21.
  48. Tercyak KP, Peshkin BN, Demarco TA, Patenaude AF, Schneider KA, Garber JE, Valdimarsdottir HB, Schwartz MD. Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children. Genet Test. 2007; 11(3):249-55.
  49. Schneider KA, Chittenden AB, Branda KJ, Keenan MA, Joffe S, Patenaude AF, Reynolds H, Dent K, Eubanks S, Goldman J, Leroy B, Warren NS, Taylor K, Vockley CW, Garber JE. Ethical issues in cancer genetics: I 1) whose information is it? J Genet Couns. 2006 Dec; 15(6):491-503.
  50. Patenaude AF, Dorval M, DiGianni LS, Schneider KA, Chittenden A, Garber JE. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. J Clin Oncol. 2006 Feb 01; 24(4):700-6.
  51. Patenaude AF, Kupst MJ. Psychosocial functioning in pediatric cancer. J Pediatr Psychol. 2005 Jan-Feb; 30(1):9-27.
  52. Patenaude AF, Kupst MJ. Introduction to the special issue: surviving pediatric cancer: research gains and goals. J Pediatr Psychol. 2005 Jan-Feb; 30(1):5-8.
  53. Patenaude AF. . The Role of the psychologist in genetics clinical care. In Jenkins J. & Lea D. (Eds.), Translating Genomics into Clinical Care: A Case Based Approach. 2005; In Press.
  54. Patenaude AF. . Genetic testing and psychology. In Patrinos G and Ansorge W (Eds.) Molecular Diagnostics. 2005; In Press.
  55. Patenaude AF & Schneider KA. . Genetic issues. In Brown R. (Ed.) Pediatric Hematology/Oncology: A Biopsychsocial Approach. 2005; In Press.
  56. Patenaude AF. . Genetic Testing for Cancer: Psychological Approaches to Helping Patients and Families. Forward by Francis Collins, M.D., Ph.D. 2004.
  57. Dorval M, Digianni L, Garber JE, Patenaude AF. Communication of BRCA1/2 test results to first-degree relatives (FDRs): Factors predicting who women tell. J Clin Oncol. 2004 Jul 15; 22(14_suppl):1010.
  58. Mertens, A, Riley A, Patenaude, AF, Bursch, B, Robison, L, Zeltzer, L. . Health and well-being in adolescent survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS). Presented at the NCI Cancer Survivorship Pathways to Health After Treatment Conference, Washington D.C. . 2004.
  59. Dorval M, DiGianni L, Garber J & Patenaude AF. . Family communication of BRCA1/2 test results to first-degree relatives (FDRs): Factors predicting who women tell. Presented at the American Society of Clinical Oncology, New Orleans, Louisiana. . 2004.
  60. Schneider KA, DiGianni LM, Patenaude AF, Klar N, Stopfer JE, Calzone KA, Li FP, Weber BL, Garber JE. Accuracy of cancer family histories: comparison of two breast cancer syndromes. Genet Test. 2004; 8(3):222-8.
  61. Patenaude AF. . Genetic testing: Ethical, legal, and social Aspects. In Anderson N (Ed.), Encyclopedia of Health and Behavior. 2004; 368-374.
  62. Kupst MJ, Patenaude AF, Walco GA, Sterling C. Clinical trials in pediatric cancer: parental perspectives on informed consent. J Pediatr Hematol Oncol. 2003 Oct; 25(10):787-90.
  63. Patenaude AF & Orozco, S. . Psychological and peer consultation needs of 108 women who have had or are considering prophylactic mastectomy. Presented at the 6th World Congress of Psycho-Oncology, Banff, Canada. 2003.
  64. Patenaude AF, Guttmacher AE, Collins FS. Psychologists' contributions to the genetic revolution. Am Psychol. 2003 Apr; 58(4):319-20.
  65. Patenaude AF. Pediatric psychology training and genetics: what will twenty-first-century pediatric psychologists need to know? J Pediatr Psychol. 2003 Mar; 28(2):135-45.
  66. Patenaude AF. . Genetic Issues. American Psychological Association Decade of Behavior Videotape Series on Behavioral Health and Health Counseling . 2003.
  67. Patenaude AF, Orozco, S., Kaelin, C, Farkas, W, Garber JE, Matory, Y, Mayzel, K, McCormick, S, Parry, B, and Smith, BL. . Truth and beauty: Women’s emotional experience of prophylactic mastectomy. Presented at American Association for Cancer Research Frontiers in Cancer Prevention Research Conference, Boston MA, October 14-18, 2002. Selected for Breast Cancer Poster Discussion session . 2002.
  68. Patenaude AF and Orozco S. . Psychological and peer consultation needs of women who have had or are considering prophylactic mastectomy. Presented at Department of Defense Breast Cancer Research Program Era of Hope meeting, Orlando FL, September 25-28, 2002 . 2002.
  69. Patenaude AF, Guttmacher AE, Collins FS. Genetic testing and psychology. New roles, new responsibilities. Am Psychol. 2002 Apr; 57(4):271-82.
  70. Patenaude AF, Last B. Cancer and children: where are we coming from? Where are we going? Psychooncology. 2001 Jul-Aug; 10(4):281-3.
  71. Jenkins, J, Blitzer M, Boehm K, Feetham S, Gettig E, Johnson A, Lapham EV, Patenaude AF, Reynolds PP, and Guttmacher AE. Recommendations of core competencies in genetics essential for all health professionals. Genetics in Medicine. 2001; 3(2):155-159.
  72. PREDICT: Predisposition Risk Education and Information about Cancer Testing. Expert Advisor for CD-ROM for women and men undergoing cancer genetic testing . 2001.
  73. Patenaude AF. . Genetic testing and family relationships: Mutual impact and future implications. In Sarason B. & Duck S. (Eds.) Personal Relationships: Implications for Clinical and Community Psychology. 2001.
  74. Patenaude AF, Schneider, DiGianni L, Li FP, and Garber JE. . Cancer worry, distress, and health behaviors among members of Li-Fraumeni Syndrome families undergoing p53 genetic testing. Presented at A Decade of ELSI Research Conference, Natcher Center, Bethesda MD. 2001.
  75. Schneider KA, Kieffer SA, Patenaude AF. BRCA1 testing and informed consent in a woman with mild retardation. J Genet Couns. 2000 Oct; 9(5):411-6.
  76. Dorval M, Patenaude AF, Schneider KA, Kieffer SA, DiGianni L, Kalkbrenner KJ, Bromberg JI, Basili LA, Calzone K, Stopfer J, Weber BL, Garber JE. Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs. J Clin Oncol. 2000 May; 18(10):2135-42.
  77. We Can Cope: When A Parent Has Cancer. Expert Advisor for film series: Parent, Child, and Adolescent films. 2000.
  78. Patenaude AF. . A different normal: How children and adolescents cope when their parent has cancer. In Baider L, Cooper GL, and De-Nour AT (Eds.) Cancer and the Family. 2000; 239-255.
  79. Bowen DJ, Patenaude AF, Vernon SW. Psychosocial issues in cancer genetics: from the laboratory to the public. Cancer Epidemiol Biomarkers Prev. 1999 Apr; 8(4 Pt 2):326-8.
  80. Patenaude AF. . Pratiques de medecine predictive aux Etats-Unis d'Amerique. In K.Malek (Ed.), La Medecine Predictive de l'Homme Sain au XXIeme Siecle. 1999; 25-28.
  81. Bowen DJ, Patenaude AF, and Vernon SW. . Psychosocial issues in cancer genetics: From the laboratory to the public. Cancer, Epidemiology, Biomarkers, and Prevention. 1999; 8(4):326-328.
  82. Linn S, Beardslee W, Patenaude AF. . "I'm Still Me". [Videocassette on school re-entry for cancer patients.] Reissued in 2000. 1998.
  83. Patenaude AF. . Cancer susceptibility testing: risks, benefits, and personal beliefs. In Clarke A, (Ed.). Genetic Testing of Children. 1998; 145-154.
  84. Hays D, Dolgin M, Steele L, Patenaude AF, Hewett KD, Ruymann F, Ruccione K, Sallan SE, and Siegel SE. Educational achievement, employment and workplace experience of adult survivors of childhood cancer. The International Journal of Pediatric Hematology/Oncology. 1997; 4:327-337.
  85. Patenaude AF, Basili L, Fairclough DL, Li FP. Attitudes of 47 mothers of pediatric oncology patients toward genetic testing for cancer predisposition. J Clin Oncol. 1996 Feb; 14(2):415-21.
  86. Patenaude AF. The genetic testing of children for cancer susceptibility: ethical, legal, and social issues. Behav Sci Law. 1996; 14(4):393-410.
  87. Patenaude AF, Schneider KA, Kieffer SA, Calzone KA, Stopfer JE, Basili LA, Weber BL, and Garber JE . Acceptance of invitations for p53 and BRCA1 predisposition testing: Factors influencing potential utilization of cancer genetic testing. . Psycho-Oncology. 1996; 5:241-250.
  88. Die-Trill M, Bromberg J, Lavally B, Portales LA, Sanfeliz A, & Patenaude AF. Social skills development in boys with brain tumors: a group approach. Journal of Psycho-social Oncology. 1996; 14:23-43.
  89. Schneider KA, Patenaude AF, Garber JE. Testing for cancer genes: decisions, decisions. Nat Med. 1995 Apr; 1(4):302-3.
  90. Garber JE, Patenaude AF. Ethical, social and counselling issues in hereditary cancer susceptibility. Cancer Surv. 1995; 25:381-97.
  91. Kunin HM, Patenaude AF, Grier HE. Suicide risk in pediatric cancer patients: An exploratory study. . Psycho-Oncology. 1995; 4:149-155.
  92. Schneider KA, Patenaude AF, and Garber JE. . Testing for cancer genes: Decisions, decisions. . Nature Medicine . 1995; (1):302-303.
  93. Garber JE & Patenaude AF. Ethical, social and counseling issues in hereditary cancer susceptibility. In Ponder BAJ,(Ed.) Cancer Surveys: Genetics and Cancer: A Second Look. 1995; 381-397.
  94. Breyer J, Kunin H, Kalish LA & Patenaude AF. The adjustment of siblings of pediatric cancer patients - a sibling and parent perspective. Psycho-Oncology. 1993; 2:201-208.
  95. Hays DM, Landsverk J, Sallan SE, Hewett KD, Patenaude AF, Schoonover D, Zilber SL, Ruccione K, Siegel SE. Educational, occupational, and insurance status of childhood cancer survivors in their fourth and fifth decades of life. J Clin Oncol. 1992 Sep; 10(9):1397-406.
  96. Li FP, Garber JE, Friend SH, Strong LC, Patenaude AF, Juengst ET, Reilly PR, Correa P, Fraumeni JF. Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals. J Natl Cancer Inst. 1992 Aug 05; 84(15):1156-60.
  97. Patenaude AF. Psychological impact of bone marrow transplantation: current perspectives. Yale J Biol Med. 1990 Sep-Oct; 63(5):515-9.
  98. Patenaude AF, Hirsch D, Breyer J, Astbury J, Berman S, Kluner KJ, Hewett K, Shanahan J, and Woodburn S. Psychosocial effects of transfusion-related HIV infection in pediatric cancer patients. Journal of Psychosocial Oncology. 1990; 8:41-58.
  99. Atkins DM, Patenaude AF. Psychosocial preparation and follow-up for pediatric bone marrow transplant patients. Am J Orthopsychiatry. 1987 Apr; 57(2):246-252.
  100. Patenaude AF, Rappeport JM, Smith BR. The physician's influence on informed consent for bone marrow transplantation. Theor Med. 1986 Jun; 7(2):165-79.
  101. Linn S, Beardslee W, Patenaude AF. Puppet therapy with pediatric bone marrow transplant patients. J Pediatr Psychol. 1986 Mar; 11(1):37-46.
  102. Patenaude AF, Levinger L, Baker K. Group meetings for parents and spouses of bone marrow transplant patients. Soc Work Health Care. 1986; 12(1):51-65.
  103. Patenaude AF & Rappeport JM. Collaboration between hematologists and mental health professionals as members of a bone marrow transplant team. Journal of Psychosocial Oncology. 1984; 2:81-92.
  104. Patenaude AF, Rappeport JM. Surviving bone marrow transplantation: the patient in the other bed. Ann Intern Med. 1982 Dec; 97(6):915-8.
  105. Patenaude AF, Shwachman H. . Psychological adaptation to chronic illness: A group discussion with cystic fibrosis patients. In Kutscher AH (Ed.), Medical Care of the Dying Patient. 1982.
  106. Patenaude AF, Szymanski L, Rappeport J. Psychological costs of bone marrow transplantation in children. Am J Orthopsychiatry. 1979 Jul; 49(3):409-22.
  107. Farkas A. Research on families of terminally ill children: problems and rewards. Journal of Clinical Child Psychology. 1974; 3:41-43.
  108. Patenaude, A.F. Adaptation of patients, siblings, and mothers to cystic fibrosis [dissertation]. 1973.
  109. Farkas A, Schnell R. A psychological study of family adjustment to cystic fibrosis. In Patterson PR, Denning C, Kutscher AH (Eds.), Psychological Aspects of Cystic Fibrosis . 1973; 202-213.
  110. Farkas A & Schnell R. A psychological study of family adjustment to cystic fibrosis. Journal of Thanatology. 1971; 1:409-417.
  111. Pierce R, Schnable PG, & Farkas A. Teaching internalization behavior to clients. Psychotherapy, Research, Theory, & Practice. 1970; 7:217-220.
LIke ThisLIke ThisLIke This


Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

Dana-Farber/Boston Children's Cancer and Blood Disorders Center is one of the top research centers in the world for pediatric cancers and blood diseases. It brings together laboratory scientists and clinical researchers from Dana-Farber Cancer Institute and Boston Children’s Hospital in a single program. We investigate pediatric cancers and non-malignant blood disorders from every angle—from examining cells under the microscope to tracking the effectiveness of current drug regimens using the most advanced molecular methods—so that we can create better treatments for children seen here and around the world.

Learn more